Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Thebault

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Scientific Reports|November 25, 2024
The combination of CSF neurofilament light chain and glial fibrillary acidic protein improves the prediction of long-term confirmed disability worsening in multiple sclerosisSimon Thebault, Seyed-Mohammad Fereshtehnejad, Hailey P Bergman, et al.
Multiple Sclerosis and Related Disorders|January 25, 2022
High or increasing serum NfL is predictive of impending multiple sclerosis relapsesSimon Thebault, Michael Reaume, Ruth Ann Marrie, et al.
Plos One|June 20, 2015
Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 VaccinationSimon Thebault, Patrick Waters, Matthew D Snape, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 14, 2019
High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MSSimon Thebault, Daniel R Tessier, Hyunwoo Lee, et al.
Gene Therapy|April 25, 2022
Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophyAoife Reilly, Marc-Olivier Deguise, Ariane Beauvais, et al.
Multiple Sclerosis and Related Disorders|April 3, 2022
Mesenchymal stem cell therapy and cognition in MS: Preliminary findings from a phase II clinical trialJason A Berard, Mark S Freedman, Ruth Ann Marrie, et al.
Clinical Proteomics|August 29, 2023
Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosisDorsa Sohaei, Simon Thebault, Lisa M Avery, et al.
Diagnosis (Berlin, Germany)|February 14, 2023
Quantitation of neurofilament light chain protein in serum and cerebrospinal fluid from patients with multiple sclerosis using the MSD R-PLEX NfL assayAntigona Ulndreaj, Dorsa Sohaei, Simon Thebault, et al.
Multiple Sclerosis and Related Disorders|November 4, 2024
MRI graph parameters are longitudinal markers of neuronal integrity in multiple sclerosisMilad Hamwi, Simon Thebault, Gerd Melkus, et al.
Clinical Proteomics|June 16, 2024
Identification of brain-enriched proteins in CSF as biomarkers of relapsing remitting multiple sclerosisLincoln I Wurtz, Evdokiya Knyazhanskaya, Dorsa Sohaei, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Scientific Reports|November 25, 2024
The combination of CSF neurofilament light chain and glial fibrillary acidic protein improves the prediction of long-term confirmed disability worsening in multiple sclerosisSimon Thebault, Seyed-Mohammad Fereshtehnejad, Hailey P Bergman, et al.
Multiple Sclerosis and Related Disorders|January 25, 2022
High or increasing serum NfL is predictive of impending multiple sclerosis relapsesSimon Thebault, Michael Reaume, Ruth Ann Marrie, et al.
Plos One|June 20, 2015
Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 VaccinationSimon Thebault, Patrick Waters, Matthew D Snape, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|September 14, 2019
High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MSSimon Thebault, Daniel R Tessier, Hyunwoo Lee, et al.
Gene Therapy|April 25, 2022
Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophyAoife Reilly, Marc-Olivier Deguise, Ariane Beauvais, et al.
Multiple Sclerosis and Related Disorders|April 3, 2022
Mesenchymal stem cell therapy and cognition in MS: Preliminary findings from a phase II clinical trialJason A Berard, Mark S Freedman, Ruth Ann Marrie, et al.
Clinical Proteomics|August 29, 2023
Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosisDorsa Sohaei, Simon Thebault, Lisa M Avery, et al.
Diagnosis (Berlin, Germany)|February 14, 2023
Quantitation of neurofilament light chain protein in serum and cerebrospinal fluid from patients with multiple sclerosis using the MSD R-PLEX NfL assayAntigona Ulndreaj, Dorsa Sohaei, Simon Thebault, et al.
Multiple Sclerosis and Related Disorders|November 4, 2024
MRI graph parameters are longitudinal markers of neuronal integrity in multiple sclerosisMilad Hamwi, Simon Thebault, Gerd Melkus, et al.
Clinical Proteomics|June 16, 2024
Identification of brain-enriched proteins in CSF as biomarkers of relapsing remitting multiple sclerosisLincoln I Wurtz, Evdokiya Knyazhanskaya, Dorsa Sohaei, et al.
Pageof 5